Skip to main content

Table 4 Association between microRNA-144-3p expression and clinicopathological parameters in non-small cell lung cancer, based on The Cancer Genome Atlas data

From: Down-regulation of microRNA-144-3p and its clinical value in non-small cell lung cancer: a comprehensive analysis based on microarray, miRNA-sequencing, and quantitative real-time PCR data

Clinicopathological feature   n mean ± SD p-value
Tissue Adjacent non-cancerous tissue 87 5.4243 ± 1.4702 < 0.001*
LUSC+LUAD 777 2.8632 ± 1.37928
Age (years) < 60 179 2.919 ± 1.37944 0.330
≥60 573 2.8038 ± 1.37438
Gender Female 323 2.8799 ± 1.37826 0.776
Male 454 2.8513 ± 1.38139
Tumor location Central lung 160 2.6915 ± 1.24372 0.604
Peripheral lung 186 2.7666 ± 1.41787
Stage Stage I-II 625 2.8494 ± 1.3589 0.630
Stage III-IV 144 2.9145 ± 1.47731
T T1-T2 647 2.9128 ± 1.37596 0.008*
T3-T4 127 2.5658 ± 1.33528
N No 504 2.8585 ± 1.39145 0.803
Yes 258 2.8324 ± 1.35039
M No 535 2.7722 ± 1.34822 0.124
Yes 22 3.277 ± 1.45564
  1. SD Standard deviation, LUAD Lung adenocarcinoma, LUSC Lung squamous cell carcinoma
  2. *p < 0.05 was considered statistically significant